Guardian Pharmacy Services (NYSE:GRDN) Shares Up 4.6% – Here’s What Happened

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s stock price was up 4.6% during trading on Monday . The company traded as high as $22.43 and last traded at $22.39. Approximately 37,424 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 188,664 shares. The stock had previously closed at $21.41.

Analyst Ratings Changes

GRDN has been the subject of several recent research reports. Truist Financial boosted their price target on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. Raymond James initiated coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set an “outperform” rating and a $21.00 target price for the company. Finally, Stephens started coverage on Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price target on the stock.

Guardian Pharmacy Services Trading Down 6.4 %

The business has a fifty day simple moving average of $21.42.

Guardian Pharmacy Services (NYSE:GRDN) last posted its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. Equities analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Insider Activity at Guardian Pharmacy Services

In other news, Director Thomas J. Salentine, Jr. bought 35,714 shares of Guardian Pharmacy Services stock in a transaction on Friday, September 27th. The shares were purchased at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the acquisition, the director now owns 35,714 shares of the company’s stock, valued at approximately $499,996. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Steven D. Cosler purchased 7,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The shares were purchased at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the transaction, the director now directly owns 17,713 shares of the company’s stock, valued at $375,869.86. This represents a 65.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Stephens Inc. AR purchased a new stake in Guardian Pharmacy Services in the third quarter worth about $189,000. Virtu Financial LLC bought a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth approximately $279,000. Barclays PLC purchased a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth approximately $311,000. Point72 DIFC Ltd purchased a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth approximately $573,000. Finally, Royce & Associates LP bought a new position in Guardian Pharmacy Services during the 3rd quarter valued at approximately $1,260,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.